Supplemental materials for the manuscript entitled "Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis"

Mendeley supplemental figure 1. Relationships between serum cytokine levels and clinical courses in SJS/TEN patients treated with the systemic steroid in combination with etanercept. The correlations between IL-18 or MIP-1α level and acute stage duration (A and C) or time of skin re-epithelialization (B and D) were tested, respectively. Correlation coefficients were determined by Pearson r correlation test in Mendeley supplemental figure 1A, and by Spearman rank correlation test in Mendeley supplemental figures 1B–1D.
Mendeley supplemental table 1. The criteria of the severity-of-illness score of toxic epidermal necrolysis (SCORTEN) for Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
Mendeley supplemental table 2. Demographic characteristics of healthy controls and patients with SJS/TEN.
Mendeley supplemental table 3. Clinical details of patients with SJS/TEN.
Mendeley supplemental table 4. Detailed characteristics of post-treatment infections in patients with SJS/TEN following the steroid monotherapy or combination therapy of steroid and etanercept.